Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Actro Khavarmianeh Pharmaceutical is an Iranian pharmaceutical company and a member of the Actoverco Group, one of the largest private pharmaceutical conglomerates in the Middle East. The company specializes in the manufacturing and distribution of a wide range of high-quality generic and licensed pharmaceutical products across various therapeutic areas, including neurology, cardiology, and gastroenterology. Operating out of advanced manufacturing facilities in the Alborz province, Actro Khavarmianeh focuses on providing affordable healthcare solutions to the Iranian market and neighboring regions. The company maintains strategic partnerships with international pharmaceutical firms to produce specialized medications under license, ensuring compliance with global GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Actro Khavarmianeh Pharmaceutical.